Top Qs
Timeline
Chat
Perspective

Frunevetmab

Feline medication for arthritis From Wikipedia, the free encyclopedia

Remove ads

Frunevetmab, sold under the brand name Solensia, is a monoclonal antibody used to treat pain associated with osteoarthritis in cats.[3] It is the first monoclonal antibody drug approved by the US Food and Drug Administration for animal use.[3] Frunevetmab is the international nonproprietary name.[5]

Quick Facts Monoclonal antibody, Type ...
Remove ads

Clinical usage

Frunevetmab is a cat-specific monoclonal antibody (a type of protein) designed to recognize and attach to a protein called nerve growth factor that is involved in the regulation of pain.[3] When frunevetmab binds to nerve growth factor, it prevents the pain signal from reaching the brain.[3]

Frunevetmab is indicated for the alleviation of pain associated with osteoarthritis in cats.[3][4]

The most common side effects seen in cats include vomiting, diarrhea, injection site pain, scabbing on the head and neck, dermatitis, and pruritus (itchy skin).[3]

Remove ads

History

In February 2021, frunevetmab was approved for medical use in the European Union.[4]

In January 2022, frunevetmab was approved for medical use in the United States.[3][6]

Development as a potential drug for humans was stopped due to risk concerns over worsening osteoarthritis.[7]

References

Bibliography

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads